1. | pitlove65965 | |
2. | sueellen | |
3. | BioElectrics007 | |
4. | AaronFrasier | |
5. | rushphile7996 |
1. | pitlove65965 | |
2. | sueellen | |
3. | BioElectrics007 | |
4. | AaronFrasier | |
5. | rushphile7996 |
1. | rushphile7996 01/26/2018 on fire |
2. | AaronFrasier 10/01/2017 Not sure. There's 25-45 million people in the United States that have IBS. I would say $20+- if it's a positive result. Hopeful... |
3. | AaronFrasier 10/01/2017 Oct 3rd - Announcing Results |
4. | pitlove65965 10/02/2017 AH looking good |
5. | pitlove65965 01/26/2018 nice surprise today |
6. | sueellen 01/26/2018 Nomura Instinet initiates as a buy, $18PT |
7. | keiththewolf94 07/24/2018 RedHill Biopharma Enrolls 400th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection |
8. | BioElectrics007 01/26/2018 Heading back to Nov prices |
9. | sueellen 10/02/2017 Ready to look ahead to Rizaport NDA and FDA guidance for ph3 Bekinda (Oct), then confirmatory 105 and Crohne's ph3 data in 8 months! Biotechs are on fire |
10. | DontGiveMeLip 10/01/2017 {Link} IBS affects between 25-45 million people in the United States. About 2 in 3 IBS are female. I would say $20 to the upside if positive results. {Image} |